Company Filing History:
Years Active: 2019
Title: Yves-Michel Frapart-Jannuad: Innovator in Cancer Treatment
Introduction
Yves-Michel Frapart-Jannuad is a notable inventor based in Ecury sur Coole, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.
Latest Patents
Frapart-Jannuad holds a patent for the use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and its derivatives to treat cancer and diseases related to excessive angiogenesis. This invention relates to a compound with a general formula that includes an aryl group, which can be substituted by various functional groups. The patent also covers methods for preparing the compound, pharmaceutical compositions containing it, and its use as a drug or prodrug in cancer treatment.
Career Highlights
He is affiliated with the Centre National de la Recherche Scientifique, where he conducts his research. His work focuses on developing pharmaceutical solutions that address critical health issues, particularly in oncology.
Collaborations
Frapart-Jannuad has collaborated with notable colleagues such as Pascal Collin and Bernard Delpech, contributing to advancements in his field.
Conclusion
Yves-Michel Frapart-Jannuad's innovative work in cancer treatment exemplifies the impact of research and development in medicine. His contributions continue to pave the way for new therapeutic approaches.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.